Grants per year
Personal profile
Research Interests
My primary clinical interest is in infections in immunocompromised patients, including stem cell and solid organ transplant recipients. I am involved in numerous clinical trials involving anti-infectives, in both the immunocompromised population and in situations involving other pediatric infections. I also study the pathogenesis of viral encephalitis, using models which focus on host-pathogen interactions in neurologic disease due to herpes simplex virus in newborns.
Transplant infectious diseases; Infections in immunocompromised pediatric patients
Certifications and Licenses
| Pediatric Infectious Diseases | |
| Pediatrics |
Training Experience
| 2004 | Residency, University of Colorado Health Science Center |
| 2007 | Fellowship, University of Washington School of Medicine |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
MD, Medicine, Emory University
… → 2001
PhD, University of Pennsylvania
… → 1991
Research interests keywords
- Brain and Nervous System
- Clinical Research
- HIV Infection
- Immunodeficiency
- Immunology
- Infectious Diseases
- Infectious Diseases in Children
- Newborn Infants
- Transplantation
- Virus Diseases
Fingerprint
Dive into the research topics where William J Muller is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
NAB-BC-3781-1202: A Phase 1, Open-Label, Two-Part Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Dose of Intravenous Lefamulin in Hospitalized Pediatric Subjects Receiving Standard of Care Antibiotic Therapy for Confirmed or
Nabriva Therapeutics Ireland DAC
6/11/20 → 8/31/50
Project: Research project
-
Consultation of Influenza Trial Design for Immuno-Compromised Pediatric Subjects
11/22/19 → 8/31/50
Project: Research project
-
Adjunctive Diagnostic Studies Completed Following Detection of Candidemia in Children: Secondary Analysis of Observed Practice From a Multicenter Cohort Study Conducted by the Pediatric Fungal Network
Wattier, R. L., Bucayu, R. F. T., Boge, C. L. K., Ross, R. K., Yildirim, I., Zaoutis, T. E., Palazzi, D. L., Vora, S. B., Castagnola, E., Avilés-Robles, M., Danziger-Isakov, L., Tribble, A. C., Sharma, T. S., Arrieta, A. C., Maron, G., Berman, D. M., Yin, D. E., Sung, L., Green, M., Roilides, E., & 29 others, Sep 1 2023, In: Journal of the Pediatric Infectious Diseases Society. 12, 9, p. 487-495 9 p.Research output: Contribution to journal › Article › peer-review
-
Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials
Simões, E. A. F., Madhi, S. A., Muller, W. J., Atanasova, V., Bosheva, M., Cabañas, F., Baca Cots, M., Domachowske, J. B., Garcia-Garcia, M. L., Grantina, I., Nguyen, K. A., Zar, H. J., Berglind, A., Cummings, C., Griffin, M. P., Takas, T., Yuan, Y., Wählby Hamrén, U., Leach, A. & Villafana, T., Mar 2023, In: The Lancet Child and Adolescent Health. 7, 3, p. 180-189 10 p.Research output: Contribution to journal › Article › peer-review
35 Scopus citations -
Erratum: Multicenter Prospective Study of Biomarkers for Diagnosis of Invasive Candidiasis in Children and Adolescents (Clin Infect Dis DOI: 10.1093/cid/ciab928)
Fisher, B. T., Boge, C. L. K., Xiao, R., Shuster, S., Chin-Quee, D., Allen, J., Shaheen, S., Hayden, R., Suganda, S., Zaoutis, T. E., Chang, Y. C., Yin, D. E., Huppler, A. R., Danziger-Isakov, L., Muller, W. J., Roilides, E., Romero, J., Sue, P. K., Berman, D., Wattier, R. L., & 13 others, Mar 1 2023, In: Clinical Infectious Diseases. 76, 5, p. 972 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Pharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants: An Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2/3 Trial
BLAZE-1 Investigators, Jul 2023, In: Infectious Diseases and Therapy. 12, 7, p. 1861-1873 13 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Resurgence of SARS-CoV-2 Delta after Omicron variant superinfection in an immunocompromised pediatric patient
Alisoltani, A., Simons, L. M., Agnes, M. F. R., Heald-Sargent, T. A., Muller, W. J., Kociolek, L. K., Hultquist, J. F., Lorenzo-Redondo, R. & Ozer, E. A., Dec 2023, In: Virology Journal. 20, 1, 246.Research output: Contribution to journal › Article › peer-review
Open Access